Prevalence, severity, and prognostic value of sleep apnea syndromes in cardiac amyloidosis

Sleep

Volumn 39, Issue 7, 2016, Pages 1333-1341

  Bodez, Diane ^a   Guellich, Aziz ^a   Kharoubi, Mounira ^a   Covali Noroc, Ala ^a   Tissot, Claire Marie ^a   Guendouz, Soulef ^a   Hittinger, Luc ^a   Dubois Randé, Jean Luc ^a   Lefaucheur, Jean Pascal ^a   Planté Bordeneuve, Violaine ^a   Adnot, Serge ^a   Boyer, Laurent ^a   Damy, Thibaud ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Cardiac amyloidosis; Heart failure; Prognosis; Sleep disordered breathing

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GADOLINIUM;

ACUTE HEART FAILURE; AGED; AMYLOIDOSIS; APNEA HYPOPNEA INDEX; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART AMYLOIDOSIS; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; LIGHT CHAIN AMYLOIDOSIS; MACROGLOSSIA; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; OXYGEN DESATURATION; OXYGEN SATURATION; PACEMAKER; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; TRANSTHYRETIN RELATED FAMILIAL AMYLOIDOSIS; ADULT; CARDIOMYOPATHIES; COMPLICATION; HEART FAILURE; MIDDLE AGED; MORTALITY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SLEEP APNEA SYNDROMES; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA SYNDROMES;

EID: 84978803259     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.5958     Document Type: Article

References (43)

1. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160:1101-6.
2. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010;122:352-60.
3. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007;49:2028-34.
4. Jilek C, Krenn M, Sebah D, et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 2011;13:68-75.
5. Damy T, Margarit L, Noroc A, et al. Prognostic impact of sleepdisordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 2012;14:1009-19.
6. Khayat R, Jarjoura D, Porter K, et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J 2015;36:1463-9.
7. Paulino A, Damy T, Margarit L, et al. Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure. Arch Cardiovasc Dis 2009;102:169-75.
8. Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail 2009;11:602-8.
9. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008;118:1080-111.
10. Javaheri S, Dempsey JA. Central sleep apnea. Compr Physiol 2013;3:141-63.
11. Tkacova R, Niroumand M, Lorenzi-Filho G, Bradley TD. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 2001;103:238-43.
12. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-904.
13. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490-4.
14. Weitzenblum E, Krieger J, Apprill M, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988;138:345-9.
15. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-36.
16. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261-4.
17. Damy T, Paulino A, Margarit L, et al. Left ventricle remodelling is associated with sleep-disordered breathing in non-ischaemic cardiopathy with systolic dysfunction. J Sleep Res 2011;20:101-9.
18. Yumino D, Redolfi S, Ruttanaumpawan P, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010;121:1598-605.
19. Palladini G, Merlini G. Systemic amyloidoses: what an internist should know. Eur J Intern Med 2013;24:729-39.
20. Mohty D, Damy T, Cosnay P, et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis 2013;106:528-40.
21. Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-12.
22. Isono S. Obesity and obstructive sleep apnoea: mechanisms for increased collapsibility of the passive pharyngeal airway. Respirol Carlton Vic 2012;17:32-42.
23. Aboussouan LS. Sleep-disordered breathing in neuromuscular disease. Am J Respir Crit Care Med 2015;191:979-89.
24. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 2009;22107-33.
25. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr J Work Group Echocardiogr Eur Soc Cardiol 2009;10:165-93.
26. Damy T, Deux J-F, Moutereau S, et al. Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis. Amyloid 2013;20:212-20.
27. Deux J-F, Damy T, Rahmouni A, Mayer J, Planté-Bordeneuve V. Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study. Amyloid 2014;21:246-5.
28. Galat A, Van Der Gucht A, Colombat M, et al. (99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 2015;22:853-7.
29. Galat A, Rosso J, Guellich A, et al. Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid 2015;22:210-20.
30. Ternacle J, Bodez D, Guellich A, et al. Causes and consequences of longitudinal left ventricular dysfunction assessed by 2D-strain echocardiography in patients with cardiac amyloidosis. JACC Cardiovasc Imaging 2016;9:126-38.
31. Carbone JE, Barker D, Stauffer JL. Sleep apnea in amyloidosis. Chest 1985;87:401-3.
32. Lesser BA, Leeper KV, Conway W. Obstructive sleep apnea in amyloidosis treated with nasal continuous positive airway pressure. Arch Intern Med 1988;148:2285-7.
33. Kiuru S, Nieminen T, Partinen M. Obstructive sleep apnoea syndrome in hereditary gelsolin-related amyloidosis. J Sleep Res 1999;8:143-9.
34. Eleid MF, Konecny T, Orban M, et al. High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:1805-9.
35. Pedrosa RP, Drager LF, Genta PR, et al. Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy. Chest 2010;137:1078-84.
36. Banno K, Shiomi T, Sasanabe R, et al. Sleep-disordered breathing in patients with idiopathic cardiomyopathy. Circ J 2004;68:338-42.
37. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999;99:1435-40.
38. Corrà U, Pistono M, Mezzani A, et al. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation 2006;113:44-50.
39. Kendzerska T, Mollayeva T, Gershon AS, Leung RS, Hawker G, Tomlinson G. Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review. Sleep Med Rev 2014;18:49-9.
40. Gottlieb JD, Schwartz AR, Marshall J, et al. Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure. J Am Coll Cardiol 2009;54:1706-2.
41. Gami AS, Olson EJ, Shen WK, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 2013;62:610-6.
42. Gellen B, Canouï-Poitrine F, Boyer L, et al. Apnea-hypopnea and desaturations in heart failure with reduced ejection fraction: are we aiming the right target? Int J Cardiol 2016;203:1022-8.
43. Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G. Obstructive sleep apnea and risk of cardiovascular events and allcause mortality: a decade-long historical cohort study. PLoS Med 2014;11:e1001599.